PER 2.53% 8.1¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-34

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,723 Posts.
    lightbulb Created with Sketch. 1461
    not entirely correct
    ive been predicting $1 by Christmas since we got our MS results some 8 yrs ago..
    But the FDA put a clinical hold on Atl1102

    since we got our DMD p 2 results I’ve been predicting >$5
    In time
    once again JG said today $1 billion possible income..
    add the EPS as low as x 10
    Do the sums ?

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.002(2.53%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $445.8K 5.519M

Buyers (Bids)

No. Vol. Price($)
2 305041 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 90105 1
View Market Depth
Last trade - 14.35pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.